CLOSEOUT LETTER

Bridge City LLC February 05, 2016

Recipient:: Bridge City LLC; United States

Issuing Office:: United States


Department of Health and Human Services	Public Health Service
	Food and Drug Administration College Park, Maryland 20740

February 5, 2016

Jeffrey Stratton
Bridge City Bulk
Bridge City LLC
3519 NE 15th Avenue, #420
Portland, OR 97212

Dear Mr. Stratton:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter Re: 470576 issued August 27, 2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,

/s/

Carrie Lawlor
Acting Branch Chief
Labeling and Dietary Supplement
Compliance Branch
Division of Enforcement
Office of Compliance
Center for Food Safety
and Applied Nutrition

Department of Health and Human Services